Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 1920
TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347308(US10202418, Compound A21)
Affinity DataIC50: 24nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347290(US10202418, Compound A2)
Affinity DataIC50: 41nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347304(US10202418, Compound A17 | US10202418, Compound A1...)
Affinity DataIC50: 255nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347289(US10202418, Compound A1)
Affinity DataIC50: 320nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347309(US10202418, Compound A22)
Affinity DataIC50: 350nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347289(US10202418, Compound A1)
Affinity DataIC50: 430nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347290(US10202418, Compound A2)
Affinity DataIC50: 1.10E+3nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347292(US10202418, Compound A4)
Affinity DataIC50: 4.00E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347300(US10202418, Compound A13)
Affinity DataIC50: 4.30E+3nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347308(US10202418, Compound A21)
Affinity DataIC50: 1.20E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetCathepsin D(Human)
Merck Patent

US Patent
LigandPNGBDBM347294(US10202418, Compound A6)
Affinity DataIC50: 1.20E+4nMAssay Description:In order to identify modulators of cathepsin D activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347307(US10202418, Compound A20)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347306(US10202418, Compound A19)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347304(US10202418, Compound A17 | US10202418, Compound A1...)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347304(US10202418, Compound A17 | US10202418, Compound A1...)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347309(US10202418, Compound A22)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347303(US10202418, Compound A16)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347302(US10202418, Compound A15)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347301(US10202418, Compound A14)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347300(US10202418, Compound A13)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347299(US10202418, Compound A12)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347298(US10202418, Compound A10)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347297(US10202418, Compound A9)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347296(US10202418, Compound A8)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347295(US10202418, Compound A7)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347294(US10202418, Compound A6)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347293(US10202418, Compound A5)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347292(US10202418, Compound A4)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent

TargetRenin(Human)
Merck Patent

US Patent
LigandPNGBDBM347291(US10202418, Compound A3)
Affinity DataIC50: 3.00E+4nMAssay Description:In order to identify modulators of renin activity, a continuous enzymatic test was carried out with a synthetic peptide which carries a fluorescent g...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
Go to US Patent